Development Level

Tbio 4 | 10,625
Tchem 2 | 1,890

Disease

glioblastoma 5 | 5,572
ovarian cancer 5 | 8,484
Cancer 4 | 2,346
Waldenstrons macroglobulinemia 4 | 765
lung cancer 4 | 4,466
Multiple myeloma 3 | 1,327
atypical teratoid/rhabdoid tumor 3 | 1,095
diabetes mellitus 3 | 1,663
medulloblastoma, large-cell 3 | 6,234
pediatric high grade glioma 3 | 2,712
primitive neuroectodermal tumor 3 | 3,031
psoriasis 3 | 6,685
Allergic hypersensitivity disease 2 | 123
Allergic rhinitis 2 | 91
Asthma 2 | 349
Bladder Neoplasm 2 | 109
Breast cancer 2 | 3,094
Dermatitis 2 | 107
Diarrhea 2 | 155
Eosinophilia 2 | 65
Fever 2 | 34
Glomerulonephritis 2 | 36
HIV Infections 2 | 100
Heart disease 2 | 279
Hypersensitivity reaction type II disease 2 | 235
Inflammatory bowel disease 2 | 142
Influenza 2 | 142
Kidney disease 2 | 396
Leukopenia 2 | 42
Lung disease 2 | 132
Malaria 2 | 140
Multiple Sclerosis 2 | 498
Pain 2 | 70
Prostatic Neoplasms 2 | 471
Rheumatoid Arthritis 2 | 1,160
Severe Combined Immunodeficiency 2 | 46
Werner syndrome 2 | 29
acute myeloid leukemia 2 | 780
acute quadriplegic myopathy 2 | 1,157
astrocytoma 2 | 1,493
colon cancer 2 | 1,475
gastric carcinoma 2 | 832
lung adenocarcinoma 2 | 2,713
mucosa-associated lymphoid tissue lymphoma 2 | 480
osteosarcoma 2 | 7,933
pilocytic astrocytoma 2 | 3,086
sarcoidosis 2 | 358
sonic hedgehog group medulloblastoma 2 | 1,482
systemic lupus erythematosus 2 | 156
tuberculosis 2 | 1,557
Actinic keratosis 1 | 22
Acute cystitis 1 | 37
Adenocarcinoma 1 | 115
Alopecia areata 1 | 37
Amnesia 1 | 17
Anorexia 1 | 15
Ataxia telangiectasia 1 | 31
Bacterial vaginosis 1 | 15
Barrett Esophagus 1 | 16
Brain Neoplasms 1 | 23
Bronchiectasis 1 | 29
Celiac disease 1 | 112
Chlamydia 1 | 18
Chronic Obstructive Airway Disease 1 | 47
Common variable immunodeficiency 1 | 72
Edema 1 | 38
Fatty Liver 1 | 48
Gastritis 1 | 44
Hepatitis 1 | 61
Hepatolenticular Degeneration 1 | 24
Herpes simplex 1 | 19
Human immunodeficiency virus infectious disease 1 | 92
Hyperactive behavior 1 | 31
Hypotension 1 | 53
Juvenile rheumatoid arthritis 1 | 104
Leishmaniasis, Visceral 1 | 13
Leprosy 1 | 77
Liver Cirrhosis 1 | 101
Lymphatic system disease 1 | 14
Measles 1 | 20
Neoplasms, Experimental 1 | 33
Neoplastic Cell Transformation 1 | 81
Otitis media 1 | 32
Pancreatitis 1 | 97
Pulmonary Fibrosis 1 | 66
Pulmonary hypertension 1 | 52
Schistosomiasis 1 | 38
Sinusitis 1 | 30
Spinal cord disease 1 | 22
Staphylococcal Infections 1 | 4
Streptococcal pneumonia 1 | 6
Synovitis 1 | 38
T cell deficiency 1 | 7
Tetanus 1 | 66
Thyroid Neoplasm 1 | 33
Toxic shock syndrome 1 | 28
Toxoplasmosis 1 | 16
Tropical spastic paraparesis 1 | 17
Type 1 diabetes mellitus 1 | 101
Uveitis 1 | 103

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444
Liver and Pancreas 5 | 18,136

Target Family

Non-IDG 6 | 11,971

Grant Application

5R01HL062588-04 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin enhancer-binding factor 2 ILF2 Tbio Non-IDG -1.51960 36.4 249
Interleukin enhancer-binding factor 3 ILF3 Tbio Non-IDG -2.09543 135.8 239
X-ray repair cross-complementing protein 5 XRCC5 Tbio Non-IDG -2.65967 456.7 712
Interleukin-8 CXCL8 Tchem Non-IDG -3.96313 9346.7 993
Interleukin-2 IL2 Tchem Non-IDG -4.34342 23652.7 1173
X-ray repair cross-complementing protein 6 XRCC6 Tbio Non-IDG -2.83582 665.6 746